Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Transition Therapeutics acquires drug discovery technology and assets of Protana

Nov. 4, 2005

NicOx and Merck extend NO-donating compound research collaboration

Nov. 4, 2005

Positive phase III results for GSK drug from Flamel collaboration

Nov. 2, 2005

Syntonix and Boehringer Ingelheim to optimize therapeutic peptides for inhalation

Oct. 26, 2005

MorphoSys begins new therapeutic antibody programs with Schering

Oct. 13, 2005

Astellas and MerLion sign drug discovery agreement

Oct. 6, 2005

CombinatoRx and Angiotech sign research and license agreement

Oct. 6, 2005

Validation of computerized prediction of polymorphs

Sep. 30, 2005

Gene Logic to seek new therapeutic indications for Pfizer drugs

Sep. 30, 2005

Lexicon Genetics updates small molecule drug discovery program

Sep. 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...